Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
This page is not indexed by search engines while we improve data quality.
Leblanc Catherine — Human Necessities
Leblanc Catherine holds 13 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Leblanc Catherine |
| Technology | Human Necessities |
| Patents in slice | 13 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2019 |
Representative patents
Notable publications linking Leblanc Catherine to Human Necessities.
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
US-9896449-B2 · Feb 20, 2018 · US
Recent filings
Latest patents from Leblanc Catherine in Human Necessities.
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Formylated N-heterocyclic derivatives as FGFR4 inhibitors
US-10189813-B2 · Jan 29, 2019 · US
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
US-9896449-B2 · Feb 20, 2018 · US
Related pages
Navigate to parent entity pages.